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Abstract 
 
Nanoengineered materials hold a vast promise of enabling revolutionary technologies, but also pose an 
emerging and potentially serious threat to human and environmental health. While there is increasing 
knowledge concerning the risks posed by engineered nanomaterials, significant inconsistencies exist 
within the current data based on the high degree of variability in the materials (e.g., synthesis method, 
coatings, etc) and biological test systems (e.g., cell lines, whole organism, etc). In this project, we 
evaluated the uptake and response of two immune cell lines (RAW macrophage and RBL mast cells) to 
nanocrystal quantum dots (Qdots) with different sizes and surface chemistries, and at different 
concentrations. The basic experimental design followed a 2 x 2 x 3 factorial model: two Qdot sizes (Qdot 
520 and 620), two surface chemistries (amine “NH2” and carboxylic acid “COOH”), and three 
concentrations (0, 1 nM, and 1 µM). Based on this design, the following Qdots from Evident 
Technologies were used for all experiments: Qdot 520-COOH, Qdot 520-NH2, Qdot 620-COOH, and 
Qdot 620-NH2. Fluorescence and confocal imaging demonstrated that Qdot 620-COOH and Qdot 620-
NH2 nanoparticles had a greater level of internalization and cell membrane association in RAW and RBL 
cells, respectively. From these data, a two-way interaction between Qdot size and concentration was 
observed in relation to the level of cellular uptake in RAW cells, and association with RBL cell 
membranes. Toxicity of both RBL and RAW cells was also significantly dependent on the interaction of 
Qdot size and concentration; the 1 µM concentrations of the larger, Qdot 620 nanoparticles induced a 
greater toxic effect on both cell lines. The RBL data also demonstrate that Qdot exposure can induce 
significant toxicity independent of cellular uptake. A significant increase in TNF-α and decrease in IL-10 
release was observed in RAW cells, and suggested that Qdot exposure induced a pro-inflammatory 
response. In contrast, significant decreases in both TNF-α and IL-4 releases were observed in RBL cells, 
which is indicative of a suppressed inflammatory response. The changes in cytokine release observed in 
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RAW and RBL cells were primarily dependent on Qdot concentration and independent of size and 
surface chemistry. Changes in the activity of superoxide dismutase were observed in RAW, but not RBL 
cells, suggesting that RAW cells were experiencing oxidative stress induced by Qdot exposure. Overall, 
our results demonstrate that the uptake/association and biomolecular response of macrophage and mast 
cells is primarily driven by an interaction between Qdot size and concentration. Based on these findings, a 
more detailed understanding of how size directly impacts cellular interactions and response will be critical 
to developing predictive models of Qdot toxicity  
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1.0 Introduction 
 
Nanotechnology holds a vast promise of enabling a wide range of transformational technologies such as 
enhanced photovoltaics,1-3 novel biomedical imaging tools,4-6 and targeted drug delivery and therapeutics.7-9 The 
rapid development of nanotechnology, however, has recently faced challenges due to potential risks with respect to 
human and the environmental health.10-15 The National Nanotechnology Initiative defines nanoscience as “research 
to discover new behaviors and properties of materials with dimensions at the nanoscale which ranges roughly from 1 
to 100 nanometers (nm).” A key aspect to this definition involves the new behaviors and properties that exist only at 
the nanoscale. While these properties and behaviors may be used to achieve significant gains (e.g., highly efficient 
energy transfer), they also raise important and unique concerns with regard to human health impact and 
environmental contamination by such materials. Currently, the health impacts associated with nanoengineered 
materials are poorly understood.16 Reports such as the ability of carbon nanotubes to cross the blood-brain barrier, 
however, suggest that the risks are real and potentially serious.17,18 More recently, asbestos-like pathogenicity has 
been observed in mice exposed to carbon nanotubes,19,20 increasing fears over the serious risks associated with 
engineering nanomaterials. The environmental health and safety issues facing nanoscience and nanotechnology are 
strikingly similar to those faced during the rise of biotechnology, in which initial excitement and promise were met 
with increasing public scrutiny and fear.21-26 Thus, there is a critical need at the global level to develop a 
fundamental understanding of the acute and chronic toxicological effects of engineered nanomaterials before fear 
and misconceptions impede future development.  
The synthesis, characterization, and application of nanoparticles and nanotubes derived from carbon-based,27-30 
metallic,31-35 and semiconductor36-40 materials have been widely reported in the literature. In particular, quantum dots 
(Qdots) have been extensively studied as fluorescent reporters for biomedical imaging.6,8,36,41 Qdots are composite 
nanocrystals composed of a semiconductor core (e.g., group II-VI and IV-VI materials), a ZnS shell, and often a 
polymer coating that enables water solubility and 
biological application (Figure 1).42,43 The 
luminescent properties of QDots depend directly 
of the size of the core, which can be precisely 
controlled during synthesis and produce Qdots 
with emission spectra across the visible range and 
into the infrared range.31,38,41 Molecular dyes are 
being increasingly replaced by Qdots for in vitro 
biological imaging based on the enhanced 
photostability and broad excitation and size-
dependent emission spectra of Qdots.7,41 In vivo 
applications of Qdots have been rather limited, 
however, as the toxicity of Qdots has not been 
fully characterized. In addition, the documented 
acute and chronic toxicity of the core materials 
such as cadmium (Cd) and lead (Pb)44  has 
increased the environmental health and safety 
awareness of Qdots in laboratory applications.   
 
 
Figure 1. Anatomy of a quantum dot (Qdot). The central 
core is composed of a semiconductor material such as 
CdSe, which is encapsulated with a ZnS shell. The Qdot is 
then coated with a polymer to enable water solubility. 
The toxicology of CdSe Qdots has been investigated in mouse model systems and a variety of cultured 
mammalian cells. These studies demonstrate a wide range in effects, from no abnormal behaviors/effects to high 
levels of toxicity and DNA damage.16 The broad spectrum of results is due to a number of factors including varied 
surface coatings, exposure conditions, and Qdot concentration. The ability to synthesize Qdots with a diverse set of 
physical properties (e.g., size, shape, composition, surface chemistry, etc.) creates an immense, multidimensional 
problem in assessing toxicological effects, and a critical challenge for predictive risk assessment. The primary goal 
of this project was to establish fundamental relationships between the physical and chemical properties of 
engineered nanoparticles and the associated biomolecular interactions and response of cells. Here we demonstrate 
that the interaction, uptake, and response of macrophage and mast cells are strongly dependent on the interaction 
between Qdot size and concentration. 
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2.0 Materials & Methods 
2.1  Cell lines and Qdots 
Two specific cell types were used for these studies: RAW 264.7 (mouse leukemic macrophage cell line) and 
RBL-2H3 (rat basophilic leukemia mast cells). Macrophages are the “professional phagocytes” responsible for 
removing unwanted biotic and abiotic materials, and initiating/propagating inflammatory reactions and oxidative 
stress. Mast cells also play an important role in inflammatory processes, particularly allergic reactions, through the 
rapid release of granules and hormonal mediators. RAW cells were maintained at 37º C with 5% CO2 in DMEM10 
(Dulbecco's Modified Eagle Medium media containing 10% fetal bovine serum; Hyclone, Logan, UT) and 1% 
penicillin-streptomycin. Cells were seeded in a glass-bottom 96-well plate at a density of 105 per well. RBL cells 
were maintained at 37º C with 5% CO2, in MEM15 (Minimum Essential Media containing 15% fetal bovine serum; 
Hyclone, Logan, UT) and 1% penicillin-streptomycin. Cells were seeded in a glass-bottom 96-well plate at a density 
of 105 per well. 
Commercially available semiconductor nanocrystal QDots (Evident Technologies, Troy, NY) were used as the 
model system based on their ubiquitous use in the research field. The cadmium and selenium used for synthesis of 
the cores of these particles raises important issues regarding the toxicological effects in humans. Qdots of two 
different sizes/emission peaks (Qdot 520: EviFluorTM 520; Qdot 620: EviFluorTM 620) and surface chemistries 
(amine, -NH2 and carboxylic acid, -COOH groups) were investigated. Safety information (e.g., MSDS toxicology 
information) for these Qdots is currently not available, aside from inferences based on the bulk metals. Three 
concentrations of the Qdots were tested: 0 (negative control), 1 nM, and 1 µM. The photoluminescence of the 
different Qdots was characterized by fluorimetry in the different media (i.e., water, DMEM10, and MEM15) to 
evaluate potential changes in spectra properties. Fluorescence was measured in each solution for the different Qdots 
sizes, surface functionalities, and concentrations. Integration of the intensity curves was determined using Spectra 
Solve software (Ames Photonics, Inc., Hurst, Texas). The values were measured by integrating the area under the 
curve of the same band pass values as used for taking the epifluorescence images.  
2.2  Experimental design and analysis 
RBL and RAW cells were seeded into glass-bottom 96-well plate at a density of 105 per well, and allowed to 
adhere for 4 hours. Qdots (Qdot 520-NH2 and -COOH; Qdot 620-NH2 and -COOH) were then added to each well to 
give final concentrations of either 1 nM or 1µM. An equal volume of water was added to negative control wells. All 
treatments were repeated in triplicates on a given plate; the entire experiment was repeated to ensure quality control. 
Qdots were maintained in the culture medium for 18 hours. After this period, the plates were centrifuged in a 
swinging bucket rotor at 400 x g for 4 min. Cells were then washed gently with a phosphate buffer saline solution 
(PBS) lacking magnesium and calcium, and centrifuged at 400 x g for 4 min. Once the appropriate media was 
replaced, brightfield and fluorescence imaging was then performed as detailed below. At 42 hours post-Qdot 
exposure, the cells were treated and imaged by brightfield and fluorescence microscopy as described for the 18 hour 
incubation. 
The experiments were executed to give a 2 x 2 x 3 factorial design with the following parameters: size (Qdot 
520 and Qdot 620), surface chemistry (NH2 and COOH), and concentration (0, 1 nM, and 1 µM). Significant main 
effects and interactions were analyzed by Three-Way Analysis of Variance, and the Holm-Sidak method for pair 
wise comparisons. 
2.3  Fluorescence microscopy and analysis 
Fluorescence and brightfield microscopy were used to evaluate Qdot uptake and cell viability at 18 and 42 
hours post-Qdot exposure. All imaging was performed on an Olympus IX-71 inverted microscope with a 60× oil 
immersion lens. Fluorescence and brightfield still images were collected using a Hamamatsu Orca or Orca II-ER 
CCD camera, and subsequently combined and analyzed using MicroSuite AnalySIS software (Olympus Soft 
Imaging Solution GmbH). The relative fluorescence (RF) of Qdots associated with a cell was estimated by: RF = 
Ic/Ib, where Ic is the mean pixel intensity of the cell, and Ib is the mean pixel intensity of the background. RF values 
were estimated for 3-5 cells per still image for each of the 12 treatments, three replicates, and duplicate experiments. 
The confluency of the cells in each image was estimated with five categories: 10 = 0-20%, 30 = 20-40%, 50 = 40-
60%, 70 = 60-80%, and 90 = 80-100%.  The confluency estimates were averaged across replicates, treatments, and 
duplicate experiments. The percent of cells with Qdots was estimated by comparing the RF values of the measured 
cells as compared with the maximum RF value for control cells plus three-times the standard error of the mean.   
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For confocal microscopy, cells were seeded onto glass coverslips at a density of 105 cells. The cells were 
exposed to the same 1 nM treatments of Qdots as described above. Following 18 hours of exposure, the media was 
removed and the cells were gently washed with PBS lacking magnesium and calcium. The coverslips were air dried, 
mounted onto a microscope slide using Cytoseal, and imaged by spinning disk confocal microscopy. 
2.4  Inflammatory and oxidative stress response 
Biochemical markers associated with inflammatory and oxidative stress pathways were evaluated at 18 hours 
post-Qdot exposure. RAW 264.7 and RBL-2H3 cells were grown in 6-well plates at a density of 5 x 106 cells per 
well using the previously described culture conditions, and exposed to the various control and Qdot treatments. 
Following an 18 hour exposure, cells were centrifuged at 400 x g for 4 min in a swinging bucket rotor, and the 
supernatant was gently removed and stored at -80°C for subsequent cytokine analysis. Cells were then detached by 
gentle pipetting or cell scraping, and washed with cold PBS. Following centrifugation, the cell pellet was thoroughly 
resuspended in Cell Lysis Solution (R&D Systems), transferred to a 1.5 mL centrifuge tube, and centrifuged at 
14,000 x g for 5 minutes at 4°C. The supernatant was transferred to a clean 1.5 mL centrifuge tube and frozen at -
80°C. 
Cytokine analysis 
The inflammatory response of cells to the different Qdot treatments was characterized by the levels of TNF-α 
and IL-10, and TNF-α and IL-4 in RAW and RBL cells, respectively. The levels of each cytokine were measured by 
commercially available enzyme-linked immunosorbent assays (ELISA). For RAW and RBL TNF-α and RAW IL-10 
ELISAs (Pierce Biotechnology, EMTNFA, ER3TNFA2, and EM2IL10), 50 µL of cell culture supernatant was 
loaded onto the plate, and incubated at room temperature for 1 hour for TNF-α assays and 3 hours for the IL-10 
assay. Following three sequential washes, a biotinylated anti-TNF-α antibody was added to each well and incubated 
at room temperature for 1-2 hours. Plates were washed three times, and a streptavidin-HRP conjugate was added and 
incubated for 30 minutes at room temperature. Following three washes, TMB (3,3´,5,5´-tetramethylbenzidine) was 
added and incubated at room temperature for 30 minutes, at which time the reaction was stopped with 0.16M 
sulfuric acid. The absorbance of each well was measured at 450 and 550 nm using a Victor 3 (Perkin Elmer) 
microplate reader. For the RBL IL-4 ELISA (R&D Systems, R4000) 50 µL of cell culture supernatant was 
transferred to the ELISA plate and incubated for 2 hours at room temperature, followed by five washes. A solution 
consisting of horseradish peroxidase-conjugated anti-IL-4 antibodies was then added and incubated for 2 hours at 
room temperature. After five washes, the TMB substrate was added, incubated for 30 minutes, and stopped with a 
hydrochloric acid solution.  The absorbance of each well was measured at 450 and 550 nm using a Victor 3 (Perkin 
Elmer) microplate reader. Three-way ANOVA was used to determine significant main effects and interactions. 
Superoxide Dismutase activity 
The superoxide dismutase activity was measured using a commercially available kit (7500-100-K, R&D 
Systems), in which the inhibition of nitroblue tetrazolium (NBT)-diformazan formation is used to measure 
superoxide dismutase activity. The reaction mixture was prepared by mixing 942.5 µL deionized water, 60 µL of 
25x Reaction Buffer, 7.5 µL Xanthine solution, 30 µL of NBT solution, and 450 µL of cell lysate that was 
previously prepared and frozem. After zeroing the spectrophotometer at 550 nm with this solution, 10 µL of 
xanthine oxidase was added and the absorbance reading was recorded at 30-second intervals for 5 minutes. The rate 
of increase in absorbance at 550 nm per minute was then calculated for each sample, and used to determine the 
percent inhibition based on a negative control (i.e., lacking any superoxide dismutase). The superoxide dismutase 
activity was then estimated based on a standard curve with known levels of the enzyme. Three-way ANOVA was 
used to determine significant main effects and interactions. 
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3.0 Results and Discussion 
3.1  Spectral analysis of Qdots 
Qdots 520 and 620 displayed peak emissions at ~517 nm and ~615 nm, respectively (Figures 1 and 2). The peak 
emission was not affected by the surface functionality (i.e., -COOH and -NH2) of the dots, or dilution in the different 
cell culture media (Figures 2 and 3). However, significant decreases (i.e., quenching) in the fluorescence were 
observed when the different Qdots were diluted in cell culture media. The integrated fluorescence of each Qdot type 
was determined in the different media to further characterize the Qdots and to quantify the observed quenching 
effects. The mean integrated fluorescence of 1 µM solutions of Qdot 620 (4.3 ± 0.6 x 107 A.U.) was significantly 
greater than the fluorescence for Qdot 520 (1.8 ± 0.1 x 107 A.U.; P < 0.006). Significant differences in the integrated 
fluorescence of the Qdots in the different media were also observed (P = 0.01), which suggests that the cell culture 
media components affect Qdot photoluminescence. No difference in the fluorescence was observed based on surface 
chemistry (P = 0.28) for either Qdot 520 or 620. 
The percent quenching of Qdots in the different media was determined by dividing the integrated fluorescence 
of the Qdots in media by the integrated fluorescence in water (Table 1). The average percent quenching for Qdots 
520 and 620 was 56 ± 3% and 57 ± 7%, respectively, and did not significantly vary based on size (P = 0.90). 
However, significant differences in quenching of the two culture media was observed (P = 0.04). DMEM10 and 
MEM15 media quenched Qdot fluorescence by 50 ± 4% and 63 ± 4%, respectively. These difference may be related 
to the increased amount of fetal bovine serum (FBS) in the MEM15 (15% PBS) as compared with DMEM10 (10% 
FBS). Adsorption of bovine serum albumin (BSA) to QDots has been shown to affect the quantum yield,45,46 
supporting this hypothesis. In addition, preliminary dynamic light scattering results (not shown) suggest significant 
aggregation of Qdots in cell culture media. Aggregation of Qdots is known to change the photoluminescent 
properties,47 and may further affect the observed quenching in our experiments. Difference in the level of quenching 
between the two Qdot sizes (Qdot 520 = 56 ± 2%; Qdot 620 = 57 ± 2%) was not observed (P = 0.90). Qdots with 
NH2-functionalized surfaces displayed a higher level of quenching (62 ± 4%) as compared to Qdots with COOH-
functionalized surfaces (51 ± 4%); these difference, however, were not significant (P = 0.123).  
 
 
Table 1.  Qdot photoluminescence. Integrated fluorescence emission of the different Qdots in water 
and cell culture medium, and the quenching effects of the different media. 
 
 Fluorescence  
(x 107 A.U.) 
Media quenching 
(%) 
520, COOH, Water 4.2  
520, COOH, DMEM10 2.0 53 
520, COOH, MEM15  1.5 65 
520, NH2, Water 4.2  
520, NH2, DMEM10 2.1 49 
520, NH2, MEM15 1.8 56 
620, COOH, Water 10.4  
620, COOH, DMEM10 4.4 57 
620, COOH, MEM15 3.0 72 
620, NH2, Water 9.8  
620, NH2, DMEM10 5.9 39 
620, NH2, MEM15 4.0 59 
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Figure 2. Qdot 520 properties. Fluorescence spectra of the Qdot 520, COOH and NH2 surface, in 
water and cell culture media. ● – Qdot 520-COOH, water; ▼ – Qdot 520-NH2, water; ■ – Qdot 520-
COOH, DMEM10; ? – Qdot 520-NH2, DMEM10; ▲ – Qdot 520-COOH, MEM15; ? – Qdot 520-
NH2, MEM15. 
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Figure 3. Qdot 620 properties. Fluorescence spectra of the Qdot 620, COOH and NH2 surface, in 
water and cell culture media. ● – Qdot 620-COOH, water; ▼ – Qdot 620-NH2, water; ■ – Qdot 620-
COOH, DMEM10; ? – Qdot 620-NH2, DMEM10; ▲ – Qdot 620-COOH, MEM15; ? – Qdot 620-
NH2, MEM15. 
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3.2  Fluorescence localization and cell toxicity 
Qdot uptake and localization 
QDots of both sizes and surface chemistries (Qdot 520-NH2 and -COOH; Qdot 620-NH2 and –COOH) were 
internalized by RAW cells within 18 hours post-exposure (Figures 4-6). Qdot fluorescence was clearly visible in 
RAW cells exposed to 1 µM concentrations of Qdots 520 and 620, and 1 nM concentrations of Qdot 620. 
Fluorescence of Qdot 520 particles was observed at the 1 nM concentrations, but was considerable less distinct 
(Figure 4). Confocal imaging of RAW cells suggests that Qdots are internalized through endocytosis, and become 
distributed throughout the cytoplasm and perinuclear space (Figure 6). Previous reports have documented the 
endocytosis of Qdots and polystyrene nanoparticles coated with negatively charged COOH groups on the 
surface.48,49  While Qdot aggregates have been observed within the nucleus,50 localization of Qdots in the nucleus of 
RAW cells was not observed in our studies. The perinuclear distribution of Qdots within RAW cells suggests that 
they are localized within recycling endosomes. These observations are consistent with previous reports of 
endosomal localization of Qdots with both COOH and NH2 surface groups.48,49 In particular, RAW cells exposed to 
Qdot 620-NH2 nanoparticles displayed greater perinuclear distribution than those exposed to Qdot 620-COOH 
nanoparticles (Figure 6). Confocal imaging also suggests that the Qdot 620 particles are internalized at a much 
greater level than the Qdot 520 particles.  
The mean fluorescence of cells exposed to the different treatments was quantified to determine which 
parameters affected Qdot uptake in RAW cells (Figure 7A). A three-way interaction among Qdot size, surface 
chemistry, and concentration was observed in at 18 hours post-exposure, and a two-way interaction between Qdot 
size and concentration was observed at 42 hours post-exposure (P < 0.001; Table 2). Pairwise comparisons within 
the different treatments and time periods were performed using the Holm-Sidak method to further delineate 
significant effects. The mean relative fluorescence of RAW cells exposed to the 1 µM concentrations was 
significantly greater than control cells and those exposed to 1 nM concentrations of Qdots at both 18 and 42 hours. 
While Qdot fluorescence was visualized at the 1 nM concentrations, significant differences between the mean 
relative fluorescence of control cells and those exposed to 1 nM concentrations of Qdots were not observed (Table 
3). This observation is due to variability in the percentage of cells with Qdots at the 1 nM treatment (Figure 7B). 
Approximately 80 – 100% of the RAW cells had fluorescence above the background level at the 1 µM 
concentrations of Qdots. In contrast, <30% of cells had Qdot fluorescence above the background level at the 1 nM 
concentrations. Together, these data suggest that, as expected, Qdot uptake is directly correlated with the 
concentration of Qdots, with greater uptake when the Qdot concentration is higher.  
Significant differences in mean fluorescence based on size were observed at the 1 µM concentrations (P < 
0.01; Table 3); differences based on size were not observed at the 1 nM concentrations. The mean fluorescence of 
RAW cells exposed to 1 µM Qdot 620-NH2, but not Qdot 620-COOH, nanoparticles was significantly greater than 
that of cells exposed to Qdot 520 nanoparticles at 18 hours post-exposure, (P < 0.01; Figure 7A), suggesting that 
surface chemistry may also play an important role. At 42 hours post-exposure, however, the mean fluorescence of 
RAW cells exposed to 1 µM Qdot 620-NH2 and Qdot 620-COOH, nanoparticles was significantly greater than that 
of cells exposed to the Qdot 520 nanoparticle treatments (Figure 7A). These data are consistent with observations 
from confocal imaging, which also suggest that the larger Qdot 620 nanoparticles are internalized to a greater extent 
than the Qdot 520 nanoparticles. While size-dependent uptake of 20 and 200 nm polymer nanoparticles has been 
reported,48 similar effects have not been documented for Qdots. In our studies, internalization displays a size and 
concentration dependency, with the larger Qdots experiencing a greater level of uptake. These observations must be 
interpreted with caution as the shape, in addition to the size, may differ for Qdots with different emission spectra.51 
Differences in shape will affect the surface area of the Qdots, and likely how interactions with cell membranes may 
occur.   
The three-way interaction observed at 18 hours post-exposure among Qdot size, surface chemistry, and 
concentration suggests that surface chemistry also played an important role in uptake (Table 3). Of all the 
treatments, a significant difference in uptake was observed only between 1 µM concentrations of Qdot 620-NH2 and 
Qdot 620-COOH nanoparticles at 18 hours (P < 0.01); this difference was not observed at 42 hours post-exposure. 
Surface chemistry-dependent effects of Qdot uptake have been reported previously, and suggest that Qdots with 
negatively-charged (i.e., COOH) surfaces are more readily internalized than those with positively charged surfaces 
(i.e., NH2).48 In contrast, our studies suggest that the surface chemistry effects are considerably less than the size and 
concentration of Qdots with respect to cellular uptake. Further investigation will be critical to fully understanding 
the role of surface chemistry and uptake in RAW cells. 
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COOH, 1 µM 
NH2, 1 nM 
NH2, 1 µM 
 
Figure 4. RAW-Qdot 520 imaging. Combined brightfield and fluorescence photomicrographs of RAW 
macrophage cells exposed to different treatments of Qdot 520 nanoparticles. 
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 18 hr 42 hr 
Control 
COOH, 1 nM 
COOH, 1 µM 
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Figure 5. RAW-Qdot 620 imaging. Combined brightfield and fluorescence photomicrographs of RAW 
macrophage cells exposed to different treatments of Qdot 520 nanoparticles. 
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520, COOH 520, NH2 620, COOH 620, NH2 
 
 
 
 
 
 
Figure 6. RAW-confocal imaging. Confocal z-slices of RAW macrophage cells exposed to 1 nM concentrations of 
QDot 520 and 620 nanoparticles with different surface chemistries (COOH and NH2) at 18 hours post-exposure. 
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Figure 7.  RAW fluorescence results. (A) Mean relative fluorescence (± standard error of the mean) of RAW cells 
at 18 (yellow bars) and 42 hours (orange bars) post-exposure to the different Qdot treatments. (B) Percent of RAW 
cells displaying fluorescence above background at 18 (yellow bars) and 42 hours (orange bars) post-exposure to the 
different Qdot treatments. 
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Table 2.  Fluorescence ANOVA statistics. P-vales from Three-way ANOVA test of main effects and interactions 
of Qdot size, surface chemistry, and concentration on the relative fluorescence of RAW and RBL cells at 18 hr and 
42 hr post-exposure. Values in bold text represent significant effects and interactions that are interpreted in the text. 
 
 RAW RBL 
 18 hr 42 hr 18 hr 42 hr 
One-way effects     
Size 0.011 <0.001 <0.001 <0.001 
Surface chemistry 0.088 0.351 0.902 <0.001 
Concentration <0.001 <0.001 <0.001 <0.001 
Two-way effects     
Size x Surface chemistry <0.001 0.258 0.860 0.003 
Size x Concentration 0.134 <0.001 <0.001 <0.001 
Surface chemistry x Concentration 0.279 0.209 0.011 <0.001 
Three-way effects     
Size x Surface chemistry x Concentration <0.001 0.625 0.717 <0.001 
 
 
 
Table 3. Fluorescence – treatment effects. Pairwise comparisons of the relative fluorescence associated with the 
Qdot different treatments (i.e., size, surface chemistry, and concentration) at 18 and 42 hours in RAW and RBL 
cells. 
 
 RAW RBL 
 18 hr 42 hr 18 hr 42 hr 
Concentration     
520, COOH, nM vs. Control No No No No 
520, NH2, nM vs. Control No No No No 
620, COOH, nM vs. Control No No Yes Yes 
620, NH2, nM vs. Control No No Yes No 
520, COOH,  µM vs. Control Yes Yes Yes Yes 
520, NH2, µM vs. Control Yes Yes Yes Yes 
620, COOH, µM vs. Control Yes Yes Yes Yes 
620, NH2, µM vs. Control Yes Yes Yes Yes 
520, COOH,  µM vs. 520, COOH, nM Yes No Yes No 
520, NH2, µM vs. 520, NH2, nM Yes Yes Yes Yes 
620, COOH, µM vs. 620, COOH, nM Yes Yes Yes Yes 
620, NH2, µM vs. 620, NH2, nM Yes Yes Yes Yes 
Size     
520, COOH, nM vs. 620, COOH, nM No No Yes No 
520, COOH, µM vs. 620, COOH,  µM No Yes Yes Yes 
520, NH2, nM vs. 620, NH2, nM No No Yes No 
520, NH2, µM vs. 620, NH2, µM Yes Yes Yes Yes 
Surface chemistry     
520, NH2, nM vs. 520, COOH, nM No No No No 
520, NH2, µM vs. 520, COOH,  µM No No No Yes 
620, NH2, nM vs. 620, COOH, nM No No No No 
620, NH2, µM vs. 620, COOH, µM Yes No No No 
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RBL cells readily interacted with all Qdot treatments (Figures 8 and 9), but displayed minimal internalization 
of Qdots (Figure 10). The overall fluorescence was greater for RBL cells exposed to the Qdot 620 treatments as 
compared with Qdot 520 nanoparticles (Figure 11A), which is similar to observations for RAW cells. Confocal 
imaging of RBL cells, however, suggests that internalization was substantially less than observed with RAW cells at 
18 hours after exposure. RBL cells exposed to the Qdots have mainly a membrane-associated distribution, with 
limited (if any) cytoplasmic distribution. Endocytosis in RBL cells is mediated through membrane receptors.52 The 
lack of internalization suggests that Qdots did not interact with the FcεRI complexes in a manner that enables 
uptake. Differences in the distribution of Qdots on RBL cell membranes also differed based on the Qdot size. Cells 
exposed to the Qdot 620 treatments displayed a higher level of association and a uniform distribution on the 
membrane surface. In contrast, the association of Qdot 520 nanoparticles with the cell membrane was much lower 
and displayed an aggregated distribution (Figure 10).  
A two-way interaction between Qdot size and concentration was observed in at 18 hours post-exposure, and a 
three-way interaction among Qdot size, surface chemistry, and concentration was observed at 42 hours post-
exposure in RBL cells (P < 0.001; Table 2). The mean relative fluorescence of RBL cells exposed to the 1 µM 
concentrations was significantly greater than control cells and those exposed to 1 nM concentrations of Qdots at 
both 18 and 42 hours (Table 3). Significant differences in the mean fluorescence of cells exposed to the 1 nM 
concentrations of Qdot 620-COOH were observed at 18  and 42 hours exposure, and 1 nM concentration of Qdot 
620-NH2 at 18 hours post-exposure (Table 3). As observed with RAW cells, the percent of RBL cells with Qdots 
varied considerably by treatment (Figure 10B), principally when cells were exposed at the 1 nM concentrations. For 
example, ~10% of RBL cells had a mean fluorescence above background at the 1 nM concentration of Qdot 520-
COOH, as compared with ~50% of cells exposed to the Qdot 620-COOH. Overall, these data suggest that Qdot 
association with RBL cell membranes is, as expected, highly dependent on the concentration of exposure. 
Size-dependent differences in mean fluorescence of RBL cells were observed at the 1 µM concentrations  of 
Qdots at 18 and 42 hours post-exposure (P < 0.01; Table 3); significant size-dependent differences were at the 1 nM 
concentrations of Qdots were observed only at 18 hours post-exposure. In these treatments, the mean fluorescence 
was significantly greater for all Qdot 620 treatments (Table 3), which agrees with observations from the confocal 
imaging. Similarly, the percent of RBL cells with Qdot fluorescence above background was higher in all Qdot 620 
treatments as compared with Qdot 520 nanoparticles (Figure 11B). Together these data suggest that Qdot size is a 
critical factor affecting the association of these nanoparticles with cell membranes. As noted earlier, this size-
dependent relationship must be interpreted with caution as shape differences may also exist,51 and affect how Qdots 
interact with cell membranes. This issue is particularly important for RBL cells based on the high degree of Qdot 
association with cell membranes and protein components.  
The three-way interaction in the mean fluorescence was observed in RBL cells at 42 hours post-exposure 
among Qdot size, surface chemistry, and concentration (Table 3), which suggests that surface chemistry may also 
play an important role. Of all the treatments, a significant difference in fluorescence was only observed between 1 
µM concentrations of Qdot 520-NH2 and Qdot 520-COOH nanoparticles at 42 hours (P < 0.01); this difference was 
not observed at 18 hours post-exposure. Because Qdots are primarily associated with the RBL membranes, surface 
chemistry (negatively versus positively charged surfaces) should play an important role controlling the interactions 
between the Qdots and the charged domains in membrane proteins. The relatively limited differences, however, 
suggest that surface chemistry plays only a minor role in driving interactions between Qdots and RBL cell 
membrane, as compared with the effects of size and concentration.  
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 18 hr 42 hr 
Control 
COOH, 1 nM 
COOH, 1 µM 
NH2, 1 nM 
NH2, 1 µM 
 
Figure 8. RBL-Qdot 520 imaging. Combined brightfield and fluorescence photomicrographs of RBL mast cells 
exposed to different treatments of Qdot 520 nanoparticles. 
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 18 hr 42 hr 
Control 
COOH, 1 nM 
COOH, 1 µM 
NH2, 1 nM 
NH2, 1 µM 
 
Figure 9. RBL-Qdot 620 imaging. Combined brightfield and fluorescence photomicrographs of RBL mast cells 
exposed to different treatments of Qdot 620 nanoparticles. 
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520, COOH 520, NH2 620, COOH 620, NH2 
 
 
 
 
 
 
Figure 10. RBL-confocal imaging. Confocal z-slices of RAW macrophage cells exposed to 1 nM concentratrions 
of QDot 520 and 620 nanoparticles with different surface chemistries (COOH and NH2) at 18 hours post-exposure. 
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Figure 11. RBL fluorescence results. (A) Mean relative fluorescence (± standard error of the mean) of RBL cells 
at 18 (yellow bars) and 42 hours (orange bars) post-exposure to the different Qdot treatments. (B) Percent of RBL 
cells displaying fluorescence above background at 18 (yellow bars) and 42 hours (orange bars) post-exposure to the 
different Qdot treatments.  
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Toxicity 
The confluency of RAW and RBL cell cultures was significantly affected by the different Qdot treatments 
(Figure 12). The confluency of control RAW cells (i.e., not exposed to Qdots) was constant (~70%) at 18 and 42 
hours post-exposure, but significantly affected by the Qdot treatments at both time points (P < 0.001; Table 4). 
Significantly lower levels of confluency were observed for RAW cells exposed to the 1 μM concentrations of Qdot 
620-COOH and Qdot 620-NH2 nanoparticles, as compared with control cells at 18 hours (Figure 11A; Table 5). 
Similarly, a two-way interaction between size and concentration was observed at 42 hours post-exposure for RAW 
cells (Table 5). The significantly lower confluency levels of RAW cells exposed to the 1 μM concentrations of Qdot 
620-COOH and Qdot 620-NH2 nanoparticles were also observed at 42 hours post-exposure (Table 6). In addition, a 
significant difference between Qdot 520-COOH and Qdot 620-COOH nanoparticles was observed, suggesting that 
toxicity is size-dependent. Overall, these data are consistent with the size-dependent relationship observed for Qdot 
uptake in RAW cells, and indicate that cytotoxicity is directly correlated with Qdot uptake. Size-dependent toxicity 
has been observed for CdTe Qdot, but suggest that the toxicity is inversely proportional to size.53 Direct comparison 
of the results, however, are difficult as the core materials and surface coatings are substantially different from those 
used in our study. Reports also suggest that Qdot-induced toxicity is dependent on the surface chemistry, but are 
conflicting with respect to whether positively- or negatively charged (NH2) surfaces induce greater toxicity. 48,50 Our 
data suggest that the cytotoxicity of Qdots in RAW cells is affected by surface chemistry, which is similar to 
observations for Qdot-induced cytotoxicity in kidney cells.54  
A significant decrease in the confluency of RBL cells was also observed based on Qdot exposure (Figure 12B). 
As observed with RAW cells, significant two-way interactions between the QDot size and concentration were 
observed at both 18 and 42 hours post-exposure (Table 5; P < 0.001). RBL cells exposed to 1 µM concentrations of 
Qdot 620-COOH and Qdot 620-NH2 nanoparticles displayed a significant decrease in confluency at both 18 and 42 
hours post-exposure (P < 0.001), whereas no change in the confluency was for Qdot 520 treatments (Figure 12B). 
The confluency of RBL cells was not affected by surface chemistry at either 18 or 42 hours post-exposure. These 
results are consistent with the observations for RAW cells in which the larger, red Qdots induced a higher level of 
cytotoxicity. A critical distinction, however, must be made with respect to the cytotoxic affects observed in these 
two cells lines. Confocal imaging suggests that Qdot are internalized by RAW cells through endocytosis, whereas 
Qdots associate primarily with RBL cell membranes and experience very little uptake. Thus, the observed 
cytotoxicity in RBLs is induced through fundamental interactions between Qdots and the cell membrane and 
membrane proteins. Because the Qdots do not enter the cell, Qdot-induced toxicity must proceed through routes that 
are discrete from those reported for internalized Qdots. The ability of Qdots to form pores and enable bursts of ion 
current to flow across cell membranes has been demonstrated,55 and represents a route for the cytotoxic response 
observed in RBL cells. Qdots may also bind electrostatically to proteins, such as ion channels, in the cell membrane 
and disrupt physiological function. 
Overall, our data demonstrate that Qdot-induced toxicity is dependent on size and concentrations, and shows 
minimal dependency on the surface charge of the polymer coating. Cytotoxicity was significantly greater for RAW 
and RBL cells exposed to the larger, Qdot 620 nanoparticles, independent of the surface functionalization. In 
addition, cytotoxicity is not limited to cells in which QDots are internalized. Substantial cytotoxicity was observed 
in RBL cells in which the Qdots were uniformly distributed on the surface of the cell membrane. Further 
investigation is needed to fully understand the mechanisms by which toxicity is induced (e.g., necrosis versus 
apoptosis) when Qdots are exclusively bound to the membrane, as compared to when Qdots are internalized. 
Understanding these mechanisms is critical to predicting the toxicity of new nanoparticles based on their 
fundamental interactions with cells. 
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Figure 12. RAW and RBL toxicity. Confluency of RAW (A) and RBL (B) cell cultures at 18 (yellow bars) and 42 
hours (orange bars) post-exposure to the different Qdot treatments. Error bars are the standard error of the mean. 
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Table 4.  Confluency ANOVA statistics. P-vales from Three-way ANOVA test of single and multiple interaction 
effects of Qdot size, surface chemistry, and concentration on the confluency of RAW and RBL cell cultures. Values 
in bold text represent significant effects and interactions that are interpreted in the text. 
 
 RAW RBL 
 18 hr 42 hr 18 hr 42 hr 
One-way effects     
Size 0.289 0.002 <0.001 <0.001 
Surface chemistry 1.00 0.066 0.464 0.065 
Concentration <0.001 <0.001 <0.001 <0.001 
Two-way effects     
Size x Surface chemistry 0.649 0.776 0.855 0.625 
Size x Concentration 0.588 <0.001 <0.001 <0.001 
Surface chemistry x Concentration 0.986 0.156 0.833 0.032 
Three-way effects     
Size x Surface chemistry x Concentration 0.937 0.352 0.701 0.882 
 
 
 
Table 5. Confluency – treatment effects. ANOVA results for the comparison of the different QDot treatments (i.e., 
size, surface chemistry, and concentration) at 18 and 42 hours of RAW and RBL cells exposed to QDots. 
 
 RAW RBL 
 18 hr 42 hr 18 hr 42 hr 
Concentration     
520, COOH, nM vs. Control No No No No
520, NH2, nM vs. Control No No No No
620, COOH, nM vs. Control No No No No
620, NH2, nM vs. Control No No No No
520, COOH,  µM vs. Control No No No No
520, NH2, µM vs. Control No No No No
620, COOH, µM vs. Control Yes Yes Yes Yes
620, NH2, µM vs. Control Yes Yes Yes Yes
520, COOH,  µM vs. 520, COOH, nM No No No No
520, NH2, µM vs. 520, NH2, nM No No No No
620, COOH, µM vs. 620, COOH, nM No Yes Yes Yes
620, NH2, µM vs. 620, NH2, nM No No Yes Yes
Size     
520, COOH, nM vs. 620, COOH, nM No No No No
520, COOH, µM vs. 620, COOH,  µM No Yes Yes Yes
520, NH2, nM vs. 620, NH2, nM No No No No
520, NH2, µM vs. 620, NH2, µM No No Yes Yes
Surface chemistry     
520, NH2, nM vs. 520, COOH, nM No No No No
520, NH2, µM vs. 520, COOH,  µM No No No No
620, NH2, nM vs. 620, COOH, nM No No No No
620, NH2, µM vs. 620, COOH, µM No No No No
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3.3  Changes in cytokine and superoxide dismutase levels  
Changes in cytokine release 
Changes in cytokine production and excretion are important signs of an inflammatory response to pathogen 
invasion and/or exposure to xenobiotics. Changes in the cytokines IL-10 and TNF-α, and IL-4 and TNF-α were 
characterized in RAW and RBL cells, respectively, to assess up-regulation of inflammatory response pathways due 
to Qdot exposure. A significant increase in TNF-α and decrease in IL-10 was observed in RAW cells exposed to the 
1 μM concentrations of all Qdot treatments, but not those exposed to the 1 nM concentrations of Qdots (Figure 13). 
A three-way interaction among size, concentration, and surface chemistry was observed for the levels of TNF-α 
(Table 6). Size- and surface chemistry-dependent difference were observed between the 1 μM concentrations of the 
Qdot 520-COOH and Qdot 620-COOH treatments, and 1 μM concentrations of the Qdot 520-COOH and Qdot 520-
NH2 treatments, respectively (Table 7). Of all treatments, the Qdot 520-COOH nanoparticles induced the greatest 
increase in TNF-α release (Figure 13A). TNF-α stimulates neutrophil proliferation during an inflammatory response, 
and thus suggests that the high concentrations of Qdots induced a pro-inflammatory response. A concentration-
dependent main effect was observed for IL-10 in RAW cells (Table 6), in which all 1 μM concentrations of Qdot 
treatments displayed a significant decrease in IL-10 release as compared with the control cells (Table 7; Figure 
13B). No change in IL-10 levels was observed for the 1 nM concentrations of Qdots. IL-10 has an anti-inflammatory 
impact on many types of immune cells (e.g., neutrophils). Thus, the decreased levels of IL-10 further confirmed a 
pro-inflammatory response of RAW cells to Qdots. A two-dimensional plot of the changes in TNF-α and IL-10 
concentrations displayed two clusters representing the two concentrations of Qdots (Figure 14), and showing the 
inverse correlation between the changes in TNF-α and IL-10 release. Similar changes in cytokine production and 
pro-inflammatory responses have been reported in response to Qdots exposure in epidermal keratinocytes, where 
changes in IL-1 beta, IL-6, and IL-8 release were observed for negatively charged (COOH), but not positively 
charged (NH2) Qdots.50 Together, these data suggest that RAW cells exhibit a pro-inflammatory response and 
related changes in cytokine release in response to high concentrations of Qdots. Limited size- and surface chemistry-
dependent effects were observed in cytokine response, and require additional investigation to fully understand these 
relationships. 
Changes in TNF-α and IL-4 concentrations were also observed in RBL cells exposed to Qdots (Figure 15).  A 
two-way interaction between size and concentration was observed with respect to changes in TNF-α (Table 6). 
Whereas TNF-α release was up-regulated in RAW cells, RBL cells exposed to the 1 µM concentrations of Qdots 
experienced significant decreases in TNF-α release as compared with the control treatments (Table 7). In contrast, 
an increase in TNF-α release was observed in RBL cells at the 1 nM concentrations of Qdot 620-COOH and Qdot 
620-NH2; only the change observed for the Qdot 620-NH2, however, was significant as compared with control cells 
(Table 7). A size-dependent difference in TNF-α level was also detected between the 1 nM treatments of Qdot 620-
NH2 and Qdot 520-NH2 (Table 7). Overall, the data suggest that TNF-α release from RBL cells was substantially 
suppressed at high concentrations of Qdots. This suppression may be related to the membrane-based association of 
Qdots in RBL cells that was observed by fluorescence and confocal microscopy. Electrostatic interactions between 
Qdots and membrane receptors and channels may inhibit the ability of RBL cells to effectively release TNF-α in 
response to Qdot exposure. Based on this proposed mechanism, the inhibition should be concentration dependent 
and be reduced at lower Qdot concentrations. The increased levels of TNF-α observed at the 1 nM treatments of 
Qdot 620 nanoparticles supports this hypothesis as a possible mechanism for suppressing TNF-α release. The levels 
of IL-4 release were also affected by Qdot exposure (Figure 15B), and displayed a two-way interaction between size 
and concentration (Table 7). As observed with TNF-α in RBL cells, significant decreases in IL-4 release were 
observed for the 1 µM treatments of Qdot 620-COOH and Qdot 620-NH2 (Table 7). The Qdot 520 nanoparticles did 
not induce changes in IL-4, suggesting that there is a size-dependency on the suppression of IL-4 release. It is 
important, however, to note that the observed changes in IL-4 were relatively minor in magnitude (i.e., < 1 pg/mL) 
and should be interpreted with a degree of caution. A two-dimensional plot of changes in TNF-α and IL-4 
concentrations displayed two clusters representing the two concentrations of Qdots (Figure 16), similar to that 
observed for RAW cells. The RBL clusters, however, suggest that both IL-4 and TNF-α release are suppressed by 
the 1 µM concentrations of Qdots, which may be directly related to the association of Qdots with the RBL cell 
membrane and associated receptors and channels. Additional analysis of intracellular proteins involved in the 
inflammatory response, however, is needed to fully discern whether the observed changes in cytokines are due to 
down-regulation in production or suppression of cytokine release. 
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Figure 13. RAW cytokine results. Changes in the levels of (A) TNF-α and (B) IL-10 measured from RAW 
macrophage cells at 18 hours after exposure to the different types of QDots. Values represent changes compared to 
control RAW cells not exposed to Qdots. Error bars are the standard error of the mean. 
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Figure 14. RAW – 2D cytokine plot. Concentrations of TNF-α and IL-10 in RAW macrophage cells at 18 hours 
after exposure to the different treatments of QDots. Symbols: 520-COOH-nM (?), 520-COOH-µM (?), 520-NH2-
nM (?), 520-NH2-µM (?), 620-COOH-nM (?), 620-COOH-µM (?), 620-NH2-nM (?), and 620-NH2-µM (?). 
Error bars are the standard error of the mean. 
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Table 6.  Cytokine ANOVA statistics. P-vales from Three-way ANOVA test of single and multiple interaction 
effects of Qdot size, surface chemistry, and concentration on the levels of TNF-α and IL-10 in RAW macrophage 
cells, and TNF-α and IL-4 in RBL mast cells. Values in bold text represent significant effects and interactions that 
are interpreted in the text. 
 
 RAW RBL 
 TNF-α IL-10 TNF-α IL-4 
One-way effects     
Size 0.005 0.256 0.052 <0.001 
Surface chemistry 0.869 0.737 0.174 0.454 
Concentration <0.001 <0.001 <0.001 <0.001 
Two-way effects     
Size x Surface chemistry 0.002 0.380 0.509 0.427 
Size x Concentration 0.003 0.576 <0.001 <0.001 
Surface chemistry x Concentration 0.242 0.763 0.018 0.863 
Three-way effects     
Size x Surface chemistry x Concentration 0.022 0.185 0.468 0.845 
 
 
 
Table 7. Cytokine – treatment effects. ANOVA results for the comparison of the different Qdot treatments (i.e., 
size, surface chemistry, and concentration) on cytokine expression in RAW and RBL cells exposed to QDots. 
 
 RAW RBL 
 TNF-α IL-10 TNF-α IL-10 
Concentration     
520, COOH, nM vs. Control No No No Yes 
520, NH2, nM vs. Control No No No No 
620, COOH, nM vs. Control No No No No 
620, NH2, nM vs. Control No No Yes No 
520, COOH,  µM vs. Control Yes Yes Yes No 
520, NH2, µM vs. Control Yes Yes Yes No 
620, COOH, µM vs. Control Yes Yes Yes Yes 
620, NH2, µM vs. Control Yes Yes Yes Yes 
520, COOH,  µM vs. 520, COOH, nM Yes Yes Yes No 
520, NH2, µM vs. 520, NH2, nM Yes Yes Yes No 
620, COOH, µM vs. 620, COOH, nM Yes Yes Yes Yes 
620, NH2, µM vs. 620, NH2, nM Yes Yes Yes Yes 
Size     
520, COOH, nM vs. 620, COOH, nM No No No No 
520, COOH, µM vs. 620, COOH,  µM Yes No No Yes 
520, NH2, nM vs. 620, NH2, nM No No Yes No 
520, NH2, µM vs. 620, NH2, µM No No No Yes 
Surface chemistry     
520, NH2, nM vs. 520, COOH, nM No No No No 
520, NH2, µM vs. 520, COOH,  µM Yes No No No 
620, NH2, nM vs. 620, COOH, nM No No No No 
620, NH2, µM vs. 620, COOH, µM No No No No 
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Figure 15. RBL cytokine results. Changes in the levels of (A) TNF-α and (B) IL-4 measured from RBL mast cells 
at 18 hours after exposure to the different types of QDots. Values represent changes compared to control RAW cells 
not exposed to Qdots. Error bars are the standard error of the mean. 
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Figure 16. RBL – 2D cytokine plot. Concentrations of TNF-α and IL-4 in RBL mast cells at 18 hours after 
exposure to the different treatments of QDots. Symbols: 520-COOH-nM (?), 520-COOH-µM (?), 520-NH2-nM 
(?), 520-NH2-µM (?), 620-COOH-nM (?), 620-COOH-µM (?), 620-NH2-nM (?), and 620-NH2-µM (?). Error 
bars are the standard error of the mean. 
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Changes in superoxide dismutase levels 
Increased levels of oxidative stress have been observed in cells exposed to single-walled carbon nanotubes56 and 
Qdots.57 Such physiological effects can lead to serious damage to proteins and DNA, and induce cell death. Cells 
mediate oxidative stress using enzymes such as superoxide dismutase, which catalyzes the dismutation of 
superoxides into oxygen and hydrogen peroxide. Changes in the activity of such enzymes may be characterized as 
indicators of oxidative stress in response to xenobiotics. The activity of superoxide dismutase was significantly 
increased in RAW cells, but not RBL cells exposed to the various Qdot treatments (Figure 17). The lack of oxidative 
stress in RBL cells may be due to the limited internalization of Qdots. A significant two-way interaction between 
size and concentration was observed in RAW cells (Table 8), with the 1 µM Qdot 520 treatment inducing the 
greatest response. The 1 µM Qdot 520-COOH, 1 nM and 1 µM Qdot 520-NH2, and 1 nM Qdot 620-COOH 
treatments displayed significant increases in superoxide dismutase activity as compared with the control RAW cells 
(Table 9). Significant size-dependent differences in superoxide dismutase activity were also observed between the 
Qdot 520-COOH and Qdot 620-COOH, and Qdot 520-NH2 and Qdot 620-NH2 treatments (Table 9). The up-
regulation of superoxide dismutase in response to Qdot may be linked to either free radical generation by the 
Qdots,58 or release of Cd2+ from the Qdot core.59 Interestingly, the oxidative stress response does not directly 
correlate with the observed toxicity induced by the Qdots. While considerable cell death in RAW cells occurred in 
the 1 µM Qdot 620 treatments (Figure 12A), only relatively smaller changes in the superoxide dismutase activity 
were observed for these treatments (Figure 17A). The significant increase in oxidative stress to the Qdot 520 
treatments, however, suggests that further evaluation of intracellular effects (e.g., DNA damage) will be important 
for understanding the full toxicology and mechanisms of cell death related to Qdot exposure.  
 
 
 
Table 8.  Superoxide dismutase ANOVA statistics. P-vales from Three-way ANOVA test of single and multiple 
interaction effects of Qdot size, surface chemistry, and concentration on the levels of superoxide dismutase (SOD) in 
RAW macrophage cells and RBL mast cells. Values in bold text represent significant effects and interactions that 
are interpreted in the text. 
 
 RAW  RBL 
One-way effects   
Size <0.001 0.806 
Surface chemistry 0.628 0.418 
Concentration <0.001 0.323 
Two-way effects   
Size x Surface chemistry 0.543 0.907 
Size x Concentration <0.001 0.749 
Surface chemistry x Concentration 0.698 0.765 
Three-way effects   
Size x Surface chemistry x Concentration 0.402 0.746 
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Table 9. Superoxide dismutase – treatment effects. ANOVA results for the comparison of the different Qdot 
treatments (i.e., size, surface chemistry, and concentration) on superoxide dismutase (SOD) levels in RAW and RBL 
cells exposed to QDots. 
 
 RAW RBL 
Concentration   
520, COOH, nM vs. Control No No 
520, NH2, nM vs. Control Yes No 
620, COOH, nM vs. Control Yes No 
620, NH2, nM vs. Control No No 
520, COOH,  µM vs. Control Yes No 
520, NH2, µM vs. Control Yes No 
620, COOH, µM vs. Control No No 
620, NH2, µM vs. Control No No 
520, COOH,  µM vs. 520, COOH, nM   No No 
520, NH2, µM vs. 520, NH2, nM No No 
620, COOH, µM vs. 620, COOH, nM No No 
620, NH2, µM vs. 620, NH2, nM No No 
Size  No 
520, COOH, nM vs. 620, COOH, nM No No 
520, COOH, µM vs. 620, COOH,  µM Yes No 
520, NH2, nM vs. 620, NH2, nM No No 
520, NH2, µM vs. 620, NH2, µM Yes No 
Surface chemistry  No 
520, NH2, nM vs. 520, COOH, nM No No 
520, NH2, µM vs. 520, COOH,  µM No No 
620, NH2, nM vs. 620, COOH, nM No No 
620, NH2, µM vs. 620, COOH, µM No No 
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Figure 17. RAW and RBL superoxide distmutase results. Levels of superoxide dismutase activity in (A) RAW 
macrophage and (B) RBL mast cells measured at 18 hours after exposure to the different types of QDots. Error bars 
are the standard error of the mean. 
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4.0 Conclusions 
 
The interaction, uptake, and biomolecular response of RAW macrophage and RBL mast cells were 
characterized as a function of the physical and chemical properties of Qdots. The basic experimental design 
followed a 2 x 2 x 3 factorial model in which the main effects and interactions among size (Qdot 520 and 620), 
surface chemistry (COOH and NH2 surface groups), and concentration (0, 1 nM and 1 µM) were evaluated by 
Three-way Analysis of Variance (ANOVA). The uptake and biomolecular response to Qdot exposure in macrophage 
cells was primarily driven by a significant two-way interaction between Qdot size and concentration. Surface 
chemistry, in general, had minimal effects on uptake, toxicity, and response in RAW cells. Epifluorescence imaging 
demonstrated that cellular uptake was significantly greater for the larger Qdot 620 nanoparticles. Further, confocal 
imaging suggested that intracellular uptake of Qdots by macrophage cells occurred through an endocytotic pathway, 
and confirmed that internalization was dependent on Qdot size. A significant interaction between size and 
concentration was also observed with respect to Qdot-induced toxicity in RAW cells, with Qdot 620 nanoparticles 
inducing the greatest level of cell death. Analysis of cytokine release by macrophage cells demonstrated an 
increased in TNF-α, and decrease in IL-10 release in response to Qdot exposure that was dependent primarily on 
concentration and independent of size and surface chemistry. The co-varying changes in cytokine release suggested 
that the cells were experiencing a pro-inflammatory immune response to Qdot exposure. Lastly, RAW cells 
displayed increase activity of superoxide dismutase, an enzyme that helps protect cells against oxidative stress, 
which also was dependent on the interaction between Qdot size and concentration. The increased superoxide 
dismutase activity was observed in response to the smaller Qdot 520 nanoparticles, but not the Qdot 620 
nanoparticles. Overall, these data demonstrate that Qdot size and concentration are the key factors that affect cellular 
uptake, toxicity, inflammatory response and oxidative stress in macrophage cells.  
The association and biomolecular response of RBL mast cells were also driven by a two-way interaction 
between Qdot size and concentration, with minimal surface chemistry-dependent effects. Qdots displayed a primary 
interaction with RBL cell membranes and very limited uptake and intracellular distribution. A fundamental 
relationship between Qdot size and membrane association and distribution was also observed in RBL cells. Qdot 
620 nanoparticles displayed a higher level of association and a more uniform distribution on the membrane surface 
as compared with the Qdot 520 nanoparticles. Quantitative fluorescence image analysis confirmed this dependency 
on the interaction of Qdot size and concentration. Despite minimal cellular uptake, a significant interaction between 
size and concentration was also observed with respect to Qdot-induced toxicity in RBL cells, with Qdot 620 
nanoparticles inducing the greatest level of cell death. RBL toxicity is likely due to Qdot binding to membrane 
receptors and channels, or compromising the integrity of the cell membrane (e.g., through pore formation). This 
observation also indicates that Qdot-induced toxicity is independent of cellular uptake. In contrast to the increased 
cytokine release by RAW cells, RBL cells displayed a decrease in the release of TNF-α and IL-4 that was dependent 
on the interaction of Qdot size and concentration. This suppression in cytokine release is consistent with the 
hypothesis that membrane receptors and channels are being affected by Qdot binding. No change in the activity of 
superoxide dismutase was observed in RBL cells, suggesting that oxidative stress was not induced by Qdot 
interactions. Together these results demonstrate that Qdot exposure can trigger considerably different responses 
based on their interaction/uptake at the cell membrane surface. 
Cell death and biomolecular response in both RBL and RAW cells were primarily observed at the high (i.e., 1 
µM) concentrations of Qdots and with the larger Qdot 620 nanoparticles. Such dose-dependent effects to xenobiotics 
are common. It will be crucial to further investigate a wide range of Qdot concentrations to establish useful 
toxicological data (e.g., LD50 values) related to the environmental and health safety of these materials. Future 
evaluation of the size-dependency and size-concentration interaction is needed to fully understand how these 
relationships correlate with toxicology. Such an understanding will be crucial to developing predictive models of 
toxicity and risk of engineered nanoparticles to human and environmental health. 
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